All presentations are available for download in PDF format unless otherwise stated.
Workshop: Implementing innovations in colorectal cancer screening: Transition to quantitative immunochemical testing
- S. Halloran: Faecal testing in colorectal cancer screening: state of art
- O. Májek: Czech National Coordination Centre for Prevention of Serious Diseases: platform for systematic introduction of innovations to early disease detection
- S. Halloran: Implementation of population-based faecal occult blood testing and transition to immunochemical tests: experience from England
- B. Seifert: Role of primary care in population-based colorectal cancer screening: current situation and future prospects
- P. Kocna: Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech Republic
- O. Májek, Š. Suchánek: Quality-assured immunochemical testing – proposal for a pilot project in the Czech Republic
Pancreatic cancer: The main challenge
- P. Poc, L. Dušek: General introduction
- N. Malats: How to identify high-risk population
- S. Barbu: Burden, prevalence and prognosis of pancreatic cancer in 2017 (the presentation is not available yet)
- J. Rosendahl: Surveillance in patients with hereditary risks or chronic pancreatitis
- P. Frič, J. Škrha, A. Šedo, P. Bušek, M. Laclav, P. Škrha, B. Seifert, M. Zavoral:
- Detection of sporadic pancreatic cancer - time for change (presentation No. 1)
- Detection of sporadic pancreatic cancer - time for change (presentation No. 2)
- A. Stunt: Patient perspective
- J. Rosendahl: Conclusion: What do we need first?
Other digestive cancers: Next to be screened?
- T. Ponchon: Screening of Barrett: Is it cost-effective? Is there a high-risk population?
- P. Burra: Surveillance of hepatocarcinoma in cirrhotic patients
- M. Dinis Ribeiro: Is there a role for screening gastric carcinoma or preneoplastic lesions
CRC screening programmes: State of the art in Europe
- M. van Leerdam: CRC screening – State of the art in Western Europe
- M. Leja: CRC screening – State of the art in Eastern Europe
Differences between ongoing programmes
State of the art in the Czech Republic – CRC screening: Czech experience in implementation
- L. Dušek: Role of comprehensive cancer care networks in organising colorectal cancer care: Experience from CANCON project
- O. Májek: Lessons learnt from cancer screening programmes as an example for establishing the Czech national coordination centre
- T. Grega, O. Májek: Practical challenges in establishing and running the Czech national colorectal cancer screening programme
Why and how to start a population based CRC screening programme?
- I. Lansdorp-Vogelaar: Cost-effectiveness analysis of a screening programme
- M. van Leerdam: Choice of screening method - factors to take into account
- I. Lansdorp-Vogelaar: Parameters for monitoring
- F. de Bels: Quality assurance and logistic organisation of a programme
Optimizing participation in ongoing CRC screening programmes
Why do we have different levels of participation in Europe?
- Influence of the programme design:
(a) Pro GP implication (F. de Bels)
(b) Cons GP implications (E. Dekker)
- Influence of the population type – How to tackle inequalities! (S. Halloran)
- Influence of the message (J. Wilkes)
- Influence of the patient associations and/or influence of a champion (L. Colemont)